Approval · Notice of Compliance 25682 · 2021
FENOFIBRATE: Notice of Compliance 25682
Issued April 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25682
- Date
- April 16, 2021
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Updating product monograph and labelling. brand name change. change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FENOFIBRATE | 02223600 | Approved |
Medicinal ingredients
- FENOFIBRATE 100 MG per CAP